Phase 4 Bipolar Disorder Trial, Recruiting (NCT07026461)

Phase 4 Bipolar Disorder Trial, Recruiting NCT07026461 Sponsor: Region Örebro County Condition: Bipolar Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT07026461 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bipolar Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older at the time of joining the trial.
You have been diagnosed by a doctor with either unipolar depression (depression on its own) or bipolar depression (depression as part of bipolar disorder), based on recognised medical guidelines.
You are willing to accept a treatment called rTMS (a non-invasive brain stimulation therapy).
You have a Swedish personal identity number.
You are able to understand the study information and give your own consent to take part.

Who may not be able to join:

If the doctor running the trial decides that one of the two treatment approaches used in the study would not be appropriate or safe for you, you may not be able to take part (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Axel Nordenskjöld, MD, PhD, Region Örebro County, Örebro University

Phone: +46196021000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07026461

Sponsor: Region Örebro County

Phase: Phase 4

Status: Recruiting

Condition: Bipolar Disorder

Trial contact: +46196021000

More information: https://clinicaltrials.gov/study/NCT07026461

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older at the time of joining the trial.
You have been diagnosed by a doctor with either unipolar depression (depression on its own) or bipolar depression (depression as part of bipolar disorder), based on recognised medical guidelines.
You are willing to accept a treatment called rTMS (a non-invasive brain stimulation therapy).
You have a Swedish personal identity number.
You are able to understand the study information and give your own consent to take part.

Who may not be able to join:

If the doctor running the trial decides that one of the two treatment approaches used in the study would not be appropriate or safe for you, you may not be able to take part (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Region Örebro County

Registry

ClinicalTrials.gov

Start date

15 December 2025

Est. completion

31 December 2030

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

reduction in the MADRS-S score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov